These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib. Furfaro AL; Piras S; Passalacqua M; Domenicotti C; Parodi A; Fenoglio D; Pronzato MA; Marinari UM; Moretta L; Traverso N; Nitti M Biochim Biophys Acta; 2014 Apr; 1842(4):613-22. PubMed ID: 24380881 [TBL] [Abstract][Full Text] [Related]
15. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells. Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160 [TBL] [Abstract][Full Text] [Related]
16. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance. Wang L; Zhang H; Sun M; Yin Z; Qian J Oncol Rep; 2015 Dec; 34(6):2969-76. PubMed ID: 26397184 [TBL] [Abstract][Full Text] [Related]
17. Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. Azuhata T; Scott D; Griffith TS; Miller M; Sandler AD J Pediatr Surg; 2006 Aug; 41(8):1431-40. PubMed ID: 16863850 [TBL] [Abstract][Full Text] [Related]
18. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma. Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318 [TBL] [Abstract][Full Text] [Related]
19. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo. Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]